BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34287575)

  • 1. Caveolin-1 promotes tumor cell proliferation and vasculogenic mimicry formation in human glioma.
    Chen W; Cheng X; Wang X; Hu W; Wang J; Liao C
    Braz J Med Biol Res; 2021; 54(10):e10653. PubMed ID: 34287575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3-mediated HOTAIRM1 promotes vasculogenic mimicry icontributionsn glioma via regulating IGFBP2 expression.
    Wu Z; Wei N
    J Transl Med; 2023 Nov; 21(1):855. PubMed ID: 38012763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma.
    Duan S
    Cancer Biomark; 2018 Feb; 21(3):565-574. PubMed ID: 29278874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L1CAM promotes vasculogenic mimicry formation by miR-143-3p-induced expression of hexokinase 2 in glioma.
    Huang Y; Zhu C; Liu P; Ouyang F; Luo J; Lu C; Tang B; Yang X
    Mol Oncol; 2023 Apr; 17(4):664-685. PubMed ID: 36708044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian target of rapamycin signaling is involved in the vasculogenic mimicry of glioma via hypoxia-inducible factor-1α.
    Huang M; Ke Y; Sun X; Yu L; Yang Z; Zhang Y; Du M; Wang J; Liu X; Huang S
    Oncol Rep; 2014 Nov; 32(5):1973-80. PubMed ID: 25175735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of HIF-1α in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis.
    Sun W; Shen ZY; Zhang H; Fan YZ; Zhang WZ; Zhang JT; Lu XS; Ye C
    Oncol Rep; 2012 Jun; 27(6):1990-2002. PubMed ID: 22470047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canstatin represses glioma growth by inhibiting formation of VM-like structures.
    Ma Y; Wu T; Zhou H; He G; Li Y; Wang B; Guo Q; Chen B; Li W
    Transl Neurosci; 2021 Jan; 12(1):309-319. PubMed ID: 34434564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
    World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Wang HF; Wang SS; Zheng M; Dai LL; Wang K; Gao XL; Cao MX; Yu XH; Pang X; Zhang M; Wu JB; Wu JS; Yang X; Tang YJ; Chen Y; Tang YL; Liang XH
    Cell Prolif; 2019 May; 52(3):e12600. PubMed ID: 30945361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
    Song Y; Mu L; Han X; Li Q; Dong B; Li H; Liu X
    J Neurooncol; 2013 Dec; 115(3):381-90. PubMed ID: 24043603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N6-methyladenosine-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma.
    Wu Z; Lin Y; Wei N
    Cancer Sci; 2023 Jan; 114(1):129-141. PubMed ID: 36086906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
    Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
    Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin-cmediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma.
    Cai HP; Wang J; Xi SY; Ni XR; Chen YS; Yu YJ; Cen ZW; Yu ZH; Chen FR; Guo CC; Zhang J; Ke C; Wang J; Chen ZP
    Cell Death Dis; 2019 Nov; 10(12):879. PubMed ID: 31754182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of vasculogenic mimicry in human gliomas.
    Liu XM; Zhang QP; Mu YG; Zhang XH; Sai K; Pang JC; Ng HK; Chen ZP
    J Neurooncol; 2011 Nov; 105(2):173-9. PubMed ID: 21533525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer.
    Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X
    Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.